- Home
- ARAY vs VOR Comparison
ARAY vs VOR Comparison
Compare ARAY & VOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARAY
- VOR
- Stock Information
- Founded
- ARAY 1990
- VOR 2015
- Country
- ARAY United States
- VOR United States
- Employees
- ARAY N/A
- VOR N/A
- Industry
- ARAY Medical/Dental Instruments
- VOR Biotechnology: Pharmaceutical Preparations
- Sector
- ARAY Health Care
- VOR Health Care
- Exchange
- ARAY Nasdaq
- VOR Nasdaq
- Market Cap
- ARAY 180.0M
- VOR 161.9M
- IPO Year
- ARAY 2007
- VOR 2021
- Fundamental
- Price
- ARAY $2.24
- VOR $1.33
- Analyst Decision
- ARAY Strong Buy
- VOR Strong Buy
- Analyst Count
- ARAY 1
- VOR 7
- Target Price
- ARAY $9.00
- VOR $11.36
- AVG Volume (30 Days)
- ARAY 669.1K
- VOR 1.1M
- Earning Date
- ARAY 01-29-2025
- VOR 11-07-2024
- Dividend Yield
- ARAY N/A
- VOR N/A
- EPS Growth
- ARAY N/A
- VOR N/A
- EPS
- ARAY N/A
- VOR N/A
- Revenue
- ARAY $444,204,000.00
- VOR N/A
- Revenue This Year
- ARAY $6.64
- VOR N/A
- Revenue Next Year
- ARAY $5.69
- VOR N/A
- P/E Ratio
- ARAY N/A
- VOR N/A
- Revenue Growth
- ARAY N/A
- VOR N/A
- 52 Week Low
- ARAY $1.40
- VOR $0.63
- 52 Week High
- ARAY $2.99
- VOR $2.56
- Technical
- Relative Strength Index (RSI)
- ARAY 60.03
- VOR 55.72
- Support Level
- ARAY $2.04
- VOR $1.29
- Resistance Level
- ARAY $2.34
- VOR $1.76
- Average True Range (ATR)
- ARAY 0.15
- VOR 0.21
- MACD
- ARAY 0.03
- VOR -0.01
- Stochastic Oscillator
- ARAY 82.76
- VOR 46.59
About ARAY Accuray Incorporated
Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, innovative treatment solutions which set the standard of radiation therapy care with the aim of helping patients live better lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention.
About VOR Vor Biopharma Inc.
Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VOR33.